Max Dahele
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Max Dahele has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Suresh Senan
Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1117 Amsterdam, The Netherlands
14 shared publications - Berend Jan Slotman
Department of Radiation Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands
11 shared publications - Wilko F. A. R. Verbakel
Amsterdam UMC location Vrije Universiteit Amsterdam, Radiation Oncology, Amsterdam, the Netherlands
5 shared publications Ben Slotman
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
3 shared publications- Jim P. Tol
Department of Radiotherapy, VU University medical center, Amsterdam, The Netherlands
3 shared publications Wilko F. Verbakel
A Department of Radiation Oncology , VU University Medical Center , Amsterdam , The Netherlands
3 shared publications
Latest Publications
- 1 March 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 144, 86-92
Systematic review of educational interventions to improve contouring in radiotherapy
- 1 March 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 144, 86-92
Systematic review of educational interventions to improve contouring in radiotherapy
- Open Access
- 6 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3696
Evaluation of an Automated Proton Planning Solution
Intensity-modulated proton therapy (IMPT) treatments are increasing, however, treatment planning remains complex and prone to variability. RapidPlanTMPT (Varian Medical Systems, Palo Alto, California, USA) is a pre-clinical, proton-specific, automated knowledge-based planning solution which could reduce variability and increase efficiency. It uses a library of previous IMPT treatment plans to generate a model which can predict organ-at-risk (OAR) dose for new patients, and guide IMPT optimization. This study details and evaluates RapidPlanTMPT. IMPT treatment plans for 50 head-and-neck cancer patients populated the model-library. The model was then used to create knowledge-based plans (KBPs) for 10 evaluation-patients. Model quality and accuracy were evaluated using model-provided OAR regression plots and examining the difference between predicted and achieved KBP mean dose. KBP quality was assessed through comparison with respective manual IMPT plans on the basis of boost/elective planning target volume (PTVB/PTVE) homogeneity and OAR sparing. The time to create KBPs was recorded. Model quality was good, with an average R2 of 0.85 between dosimetric and geometric features. The model showed high predictive accuracy with differences of TMPT demonstrated efficiency and consistency and IMPT KBPs were comparable to manual plans. Because worse OAR sparing in a KBP was not always associated with geometric-outlier warnings, manual plan checks remain important. Such an automated planning solution could also assist in clinical trial quality assurance and overcome the learning curve associated with IMPT.
- 6 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3696
Open AccessEvaluation of an Automated Proton Planning Solution
Intensity-modulated proton therapy (IMPT) treatments are increasing, however, treatment planning remains complex and prone to variability. RapidPlanTMPT (Varian Medical Systems, Palo Alto, California, USA) is a pre-clinical, proton-specific, automated knowledge-based planning solution which could reduce variability and increase efficiency. It uses a library of previous IMPT treatment plans to generate a model which can predict organ-at-risk (OAR) dose for new patients, and guide IMPT optimization. This study details and evaluates RapidPlanTMPT. IMPT treatment plans for 50 head-and-neck cancer patients populated the model-library. The model was then used to create knowledge-based plans (KBPs) for 10 evaluation-patients. Model quality and accuracy were evaluated using model-provided OAR regression plots and examining the difference between predicted and achieved KBP mean dose. KBP quality was assessed through comparison with respective manual IMPT plans on the basis of boost/elective planning target volume (PTVB/PTVE) homogeneity and OAR sparing. The time to create KBPs was recorded. Model quality was good, with an average R2 of 0.85 between dosimetric and geometric features. The model showed high predictive accuracy with differences of TMPT demonstrated efficiency and consistency and IMPT KBPs were comparable to manual plans. Because worse OAR sparing in a KBP was not always associated with geometric-outlier warnings, manual plan checks remain important. Such an automated planning solution could also assist in clinical trial quality assurance and overcome the learning curve associated with IMPT.
- Open Access
Automated Knowledge-Based Intensity-Modulated Proton Planning: An International Multicenter Benchmarking Study
Background: Radiotherapy treatment planning is increasingly automated and knowledge-based planning has been shown to match and sometimes improve upon manual clinical plans, with increased consistency and efficiency. In this study, we benchmarked a novel prototype knowledge-based intensity-modulated proton therapy (IMPT) planning solution, against three international proton centers. Methods: A model library was constructed, comprising 50 head and neck cancer (HNC) manual IMPT plans from a single center. Three external-centers each provided seven manual benchmark IMPT plans. A knowledge-based plan (KBP) using a standard beam arrangement for each patient was compared with the benchmark plan on the basis of planning target volume (PTV) coverage and homogeneity and mean organ-at-risk (OAR) dose. Results: PTV coverage and homogeneity of KBPs and benchmark plans were comparable. KBP mean OAR dose was lower in 32/54, 45/48 and 38/53 OARs from center-A, -B and -C, with 23/32, 38/45 and 23/38 being >2 Gy improvements, respectively. In isolated cases the standard beam arrangement or an OAR not being included in the model or being contoured differently, led to higher individual KBP OAR doses. Generating a KBP typically required <10 min. Conclusions: A knowledge-based IMPT planning solution using a single-center model could efficiently generate plans of comparable quality to manual HNC IMPT plans from centers with differing planning aims. Occasional higher KBP OAR doses highlight the need for beam angle optimization and manual review of KBPs. The solution furthermore demonstrated the potential for robust optimization.
Open AccessAutomated Knowledge-Based Intensity-Modulated Proton Planning: An International Multicenter Benchmarking Study
Background: Radiotherapy treatment planning is increasingly automated and knowledge-based planning has been shown to match and sometimes improve upon manual clinical plans, with increased consistency and efficiency. In this study, we benchmarked a novel prototype knowledge-based intensity-modulated proton therapy (IMPT) planning solution, against three international proton centers. Methods: A model library was constructed, comprising 50 head and neck cancer (HNC) manual IMPT plans from a single center. Three external-centers each provided seven manual benchmark IMPT plans. A knowledge-based plan (KBP) using a standard beam arrangement for each patient was compared with the benchmark plan on the basis of planning target volume (PTV) coverage and homogeneity and mean organ-at-risk (OAR) dose. Results: PTV coverage and homogeneity of KBPs and benchmark plans were comparable. KBP mean OAR dose was lower in 32/54, 45/48 and 38/53 OARs from center-A, -B and -C, with 23/32, 38/45 and 23/38 being >2 Gy improvements, respectively. In isolated cases the standard beam arrangement or an OAR not being included in the model or being contoured differently, led to higher individual KBP OAR doses. Generating a KBP typically required <10 min. Conclusions: A knowledge-based IMPT planning solution using a single-center model could efficiently generate plans of comparable quality to manual HNC IMPT plans from centers with differing planning aims. Occasional higher KBP OAR doses highlight the need for beam angle optimization and manual review of KBPs. The solution furthermore demonstrated the potential for robust optimization.
- 1 November 2018
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 129 (2) , 234-241
Feasibility of markerless 3D position monitoring of the central airways using kilovoltage projection images: Managing the risks of central lung stereotactic radiotherapy
- 1 November 2018
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 129 (2) , 234-241
Feasibility of markerless 3D position monitoring of the central airways using kilovoltage projection images: Managing the risks of central lung stereotactic radiotherapy
- 1 September 2017
- Published by Elsevier in Clinical Lung Cancer
- Vol. 18 (5) , e367-e368
Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer
- 1 September 2017
- Published by Elsevier in Clinical Lung Cancer
- Vol. 18 (5) , e367-e368
Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer
- 1 August 2017
- Published by Elsevier in Lung Cancer
- Vol. 110, 14-18
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
- 1 August 2017
- Published by Elsevier in Lung Cancer
- Vol. 110, 14-18
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
- 23 June 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 124 (1) , 182-183
Google Trends can provide objective data on the impact of radiation oncology related media events and the level of interest in specific types of treatment
- 23 June 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 124 (1) , 182-183
Google Trends can provide objective data on the impact of radiation oncology related media events and the level of interest in specific types of treatment
- 1 May 2017
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (5) , e58-e59
The Relationship between Histology, Stage, and Type of Treatment in Patients with Early-Stage Lung Cancer
- 1 May 2017
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (5) , e58-e59
The Relationship between Histology, Stage, and Type of Treatment in Patients with Early-Stage Lung Cancer
- 1 October 2016
- Published by Elsevier in Annals of Oncology
- Vol. 27 (10) , 1973
Is radical chemo-radiotherapy appropriate in patients with stage IV non-small-cell lung cancer due to cervical lymph node metastases?
- 1 October 2016
- Published by Elsevier in Annals of Oncology
- Vol. 27 (10) , 1973
Is radical chemo-radiotherapy appropriate in patients with stage IV non-small-cell lung cancer due to cervical lymph node metastases?
- Open Access
- 6 September 2016
- Published by Springer Nature in Radiation Oncology
- Vol. 11 (1) , 1-14
A critical review of recent developments in radiotherapy for non-small cell lung cancer
Lung cancer is the leading cause of cancer mortality, and radiotherapy plays a key role in both curative and palliative treatments for this disease. Recent advances include stereotactic ablative radiotherapy (SABR), which is now established as a curative-intent treatment option for patients with peripheral early-stage NSCLC who are medically inoperable, or at high risk for surgical complications. Improved delivery techniques have facilitated studies evaluating the role of SABR in oligometastatic NSCLC, and encouraged the use of high-technology radiotherapy in some palliative settings. Although outcomes in locally advanced NSCLC remain disappointing for many patients, future progress may come about from an improved understanding of disease biology and the development of radiotherapy approaches that further reduce normal tissue irradiation. At the moment, the benefits, if any, of radiotherapy technologies such as proton beam therapy remain unproven. This paper provides a critical review of selected aspects of modern radiotherapy for lung cancer, highlights the current limitations in our understanding and treatment approaches, and discuss future treatment strategies for NSCLC.
- 6 September 2016
- Published by Springer Nature in Radiation Oncology
- Vol. 11 (1) , 1-14
Open AccessA critical review of recent developments in radiotherapy for non-small cell lung cancer
Lung cancer is the leading cause of cancer mortality, and radiotherapy plays a key role in both curative and palliative treatments for this disease. Recent advances include stereotactic ablative radiotherapy (SABR), which is now established as a curative-intent treatment option for patients with peripheral early-stage NSCLC who are medically inoperable, or at high risk for surgical complications. Improved delivery techniques have facilitated studies evaluating the role of SABR in oligometastatic NSCLC, and encouraged the use of high-technology radiotherapy in some palliative settings. Although outcomes in locally advanced NSCLC remain disappointing for many patients, future progress may come about from an improved understanding of disease biology and the development of radiotherapy approaches that further reduce normal tissue irradiation. At the moment, the benefits, if any, of radiotherapy technologies such as proton beam therapy remain unproven. This paper provides a critical review of selected aspects of modern radiotherapy for lung cancer, highlights the current limitations in our understanding and treatment approaches, and discuss future treatment strategies for NSCLC.